DENTSPLY SIRONA Inc. (XRAY) Spending and interest coverage
- R&D / revenue · 12 months: Value 4.56%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.85%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 4.56% | Research and development expense / revenue. Period ending 2026-06-30. $166.00M ÷ $3.64B × 100 ≈ 4.56% |
| Stock-based compensation / revenue · 12 months | 0.85% | Share-based compensation / revenue. Period ending 2026-06-30. $31.00M ÷ $3.64B × 100 ≈ 0.85% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 166.00M USD | Research and Development Expense |
| Revenue | 3.64B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 31.00M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -310.00M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $166.00M | $3.64B | $31.00M | $-310.00M | (m) | 4.56% | 0.85% | (m) | (m) |
| 2026-03-31 | $158.00M | $3.68B | $31.00M | $-520.00M | (m) | 4.29% | 0.84% | (m) | (m) |
| 2025-12-31 | $150.00M | $3.68B | $33.00M | $-422.00M | (m) | 4.08% | 0.90% | (m) | (m) |
| 2025-09-30 | $152.00M | $3.62B | $29.00M | $-792.00M | (m) | 4.19% | 0.80% | (m) | (m) |
| 2025-06-30 | $155.00M | $3.67B | $35.00M | $-1.04B | (m) | 4.22% | 0.95% | (m) | (m) |
| 2025-03-31 | $159.00M | $3.72B | $38.00M | $-858.00M | (m) | 4.28% | 1.02% | (m) | (m) |
| 2024-12-31 | $165.00M | $3.79B | $39.00M | $-879.00M | (m) | 4.35% | 1.03% | (m) | (m) |
| 2024-09-30 | $166.00M | $3.90B | $48.00M | $-297.00M | (m) | 4.26% | 1.23% | (m) | (m) |
| 2024-06-30 | $172.00M | $3.90B | $38.00M | $-71.00M | (m) | 4.41% | 0.98% | (m) | (m) |
| 2024-03-31 | $180.00M | $3.94B | $40.00M | $-41.00M | $79.00M | 4.57% | 1.02% | -0.52× | Reported |
| 2023-12-31 | $184.00M | $3.96B | $46.00M | $-85.00M | $81.00M | 4.64% | 1.16% | -1.05× | Reported |
| 2023-09-30 | $184.00M | $3.94B | $45.00M | $-93.00M | (m) | 4.67% | 1.14% | (m) | (m) |
| 2023-06-30 | $179.00M | $3.94B | $57.00M | $-1.07B | (m) | 4.55% | 1.45% | (m) | (m) |
| 2023-03-31 | $175.00M | $3.93B | $65.00M | $-1.04B | (m) | 4.45% | 1.65% | (m) | (m) |
| 2022-12-31 | $174.00M | $3.92B | $59.00M | $-937.00M | (m) | 4.44% | 1.50% | (m) | (m) |
| 2022-09-30 | $180.00M | $4.04B | $41.00M | $-830.00M | (m) | 4.45% | 1.01% | (m) | (m) |
| 2022-06-30 | $178.00M | $4.13B | $49.00M | $520.00M | (m) | 4.30% | 1.19% | (m) | (m) |
| 2022-03-31 | $176.00M | $4.17B | $46.00M | $555.00M | (m) | 4.22% | 1.10% | (m) | (m) |
| 2021-12-31 | $171.00M | $4.25B | $48.00M | $622.00M | (m) | 4.02% | 1.13% | (m) | (m) |
| 2021-09-30 | $148.00M | $4.25B | $65.00M | $603.00M | $59.00M | 3.49% | 1.53% | 10.22× | Reported |
| 2021-06-30 | $140.00M | $4.07B | $60.00M | $526.00M | $60.00M | 3.44% | 1.47% | 8.77× | Reported |
| 2021-03-31 | $118.00M | $3.50B | $50.00M | $267.00M | $55.00M | 3.38% | 1.43% | 4.85× | Reported |
| 2020-12-31 | $115.00M | $3.34B | $47.00M | $-12.00M | $48.00M | 3.44% | 1.41% | -0.25× | Reported |
| 2020-09-30 | (m) | $3.37B | $52.60M | $-10.80M | $39.90M | (m) | 1.56% | -0.27× | Reported |
| 2020-06-30 | (m) | $3.44B | $51.50M | $17.00M | $32.00M | (m) | 1.50% | 0.53× | Reported |
| 2020-03-31 | (m) | (m) | $66.50M | $188.80M | $27.70M | (m) | (m) | 6.82× | Reported |
| 2019-12-31 | $131.30M | $4.03B | $66.20M | $360.90M | $29.40M | 3.26% | 1.64% | 12.28× | Reported |
| 2019-09-30 | (m) | (m) | $55.70M | $306.10M | $32.40M | (m) | (m) | 9.45× | Reported |
| 2019-06-30 | (m) | (m) | $45.60M | $242.10M | $35.50M | (m) | (m) | 6.82× | Reported |
| 2019-03-31 | (m) | (m) | $20.90M | $-979.50M | $37.10M | (m) | (m) | -26.40× | Reported |
| 2018-12-31 | $160.50M | (m) | $21.00M | $-958.10M | $37.30M | (m) | (m) | -25.69× | Reported |
| 2018-09-30 | (m) | (m) | $22.30M | $-1.75B | $37.50M | (m) | (m) | -46.57× | Reported |
| 2018-06-30 | (m) | (m) | $35.90M | $-1.68B | $37.60M | (m) | (m) | -44.78× | Reported |
| 2018-03-31 | (m) | $4.05B | $46.50M | $-1.58B | $37.60M | (m) | 1.15% | -41.96× | Reported |
| 2017-12-31 | $151.70M | $3.99B | $48.00M | $-1.56B | $38.30M | 3.80% | 1.20% | -40.79× | Reported |
| 2017-09-30 | (m) | (m) | $52.70M | $-721.70M | $37.70M | (m) | (m) | -19.14× | Reported |
| 2017-06-30 | (m) | (m) | $45.80M | $-703.00M | $36.30M | (m) | (m) | -19.37× | Reported |
| 2017-03-31 | (m) | (m) | $47.30M | $466.20M | $36.00M | (m) | (m) | 12.95× | Reported |
| 2016-12-31 | $128.50M | (m) | $41.30M | $454.70M | $35.90M | (m) | (m) | 12.67× | Reported |
| 2016-09-30 | (m) | (m) | $35.50M | $413.60M | $52.70M | (m) | (m) | 7.85× | Reported |
| 2016-06-30 | (m) | (m) | $31.20M | $385.60M | $53.90M | (m) | (m) | 7.15× | Reported |
| 2016-03-31 | (m) | (m) | $25.50M | $350.20M | $54.40M | (m) | (m) | 6.44× | Reported |
| 2015-12-31 | $74.90M | (m) | $25.60M | $375.20M | $55.90M | (m) | (m) | 6.71× | Reported |
| 2015-09-30 | (m) | (m) | $25.03M | $385.40M | $41.61M | (m) | (m) | 9.26× | Reported |
| 2015-06-30 | (m) | $2.78B | $23.90M | $396.43M | $44.65M | (m) | 0.86% | 8.88× | Reported |
| 2015-03-31 | (m) | $2.85B | $24.54M | $437.74M | $46.62M | (m) | 0.86% | 9.39× | Reported |
| 2014-12-31 | $80.80M | $2.92B | $25.43M | $445.60M | $46.91M | 2.76% | 0.87% | 9.50× | Reported |
| 2014-09-30 | (m) | $2.96B | $26.97M | $439.68M | $46.87M | (m) | 0.91% | 9.38× | Reported |
| 2014-06-30 | (m) | $2.95B | $26.43M | $435.12M | $45.65M | (m) | 0.90% | 9.53× | Reported |
| 2014-03-31 | (m) | $2.95B | $25.45M | $430.88M | $45.36M | (m) | 0.86% | 9.50× | Reported |
| 2013-12-31 | $85.10M | $2.95B | $25.10M | $419.17M | $49.63M | 2.88% | 0.85% | 8.45× | Reported |
| 2013-09-30 | (m) | $2.95B | $22.97M | $418.95M | $50.97M | (m) | 0.78% | 8.22× | Reported |
| 2013-06-30 | (m) | $2.94B | $23.18M | $402.60M | $53.47M | (m) | 0.79% | 7.53× | Reported |
| 2013-03-31 | (m) | $2.94B | $23.40M | $388.64M | $56.29M | (m) | 0.79% | 6.90× | Reported |
| 2012-12-31 | $85.40M | $2.93B | $22.19M | $381.94M | $56.85M | 2.92% | 0.76% | 6.72× | Reported |
| 2012-09-30 | (m) | $2.91B | $22.54M | $350.07M | $60.69M | (m) | 0.77% | 5.77× | Reported |
| 2012-06-30 | (m) | $2.84B | $21.66M | $301.21M | $62.27M | (m) | 0.76% | 4.84× | Reported |
| 2012-03-31 | (m) | $2.68B | $20.50M | $289.30M | $53.25M | (m) | 0.76% | 5.43× | Reported |
| 2011-12-31 | $66.70M | $2.54B | $20.95M | $300.73M | $43.81M | 2.63% | 0.83% | 6.86× | Reported |
| 2011-09-30 | (m) | $2.37B | $19.69M | $330.95M | $34.66M | (m) | 0.83% | 9.55× | Reported |
| 2011-06-30 | (m) | $2.29B | $18.88M | $381.57M | $24.60M | (m) | 0.82% | 15.51× | Reported |
| 2011-03-31 | (m) | $2.25B | $18.25M | $389.53M | $25.71M | (m) | 0.81% | 15.15× | Reported |
| 2010-12-31 | $49.40M | $2.22B | $18.80M | $380.27M | $25.09M | 2.22% | 0.85% | 15.16× | Reported |
| 2010-09-30 | (m) | $2.22B | $16.27M | $388.06M | $23.43M | (m) | 0.73% | 16.57× | Reported |
| 2010-06-30 | (m) | $2.21B | $16.79M | $390.58M | $22.88M | (m) | 0.76% | 17.07× | Reported |
| 2010-03-31 | (m) | $2.20B | $16.71M | $384.34M | $21.46M | (m) | 0.76% | 17.91× | Reported |
| 2009-12-31 | (m) | $2.16B | $16.28M | $381.19M | $21.90M | (m) | 0.75% | 17.41× | Reported |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | $2.19B | $17.29M | $380.42M | $32.53M | (m) | 0.79% | 11.70× | Reported |
| 2008-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-12-31 | (m) | $2.01B | $14.09M | $354.89M | $23.78M | (m) | 0.70% | 14.92× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Envista Holdings Corp (NVST) | United States | $3.866B | 46.70 |